Your browser doesn't support javascript.
loading
[The role of probiotics in the treatment of inflammatory bowel diseases]. / Place des probiotiques dans le traitement des maladies inflammatoires intestinales.
Girardin, M; Frossard, J-L.
Affiliation
  • Girardin M; Service de gastroentérologie et hépatologie, Département des spécialités de médecine, HUG, 1211 Geneve 14. marc.girardin@hcuge.ch
Rev Med Suisse ; 8(352): 1674-6, 1678, 2012 Sep 05.
Article in Fr | MEDLINE | ID: mdl-22988728
ABSTRACT
The intestinal mucosa is the site of a fundamental interaction between a large amount of foreign substances, the immune system and bacteria that colonizes the mucosa. Many gastrointestinal diseases are due to an altered interaction between all these actors, particularly inflammatory bowel diseases. As such probiotics (bacteria providing a benefit to the host) could provide an interesting solution as a therapeutic agent. The evidences supporting such use are limited but there are still some quality randomized controlled trials. The purpose of this review is to discuss the most recent evidences from the literature on the use of probiotics in the treatment of inflammatory bowel diseases.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Probiotics Type of study: Clinical_trials Limits: Humans Language: Fr Journal: Rev Med Suisse Journal subject: MEDICINA Year: 2012 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Probiotics Type of study: Clinical_trials Limits: Humans Language: Fr Journal: Rev Med Suisse Journal subject: MEDICINA Year: 2012 Document type: Article